Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank7
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P7
Near historical low
vs 2Y Ago
-4.6x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-391.95%
202490.68%
202384.47%
2022-86.69%
2021-178.60%
2020-25.43%
201914.49%
20182.11%
20177.28%
2016-184.37%